Bora Pharmaceuticals: Company Board Resolution on Promotion of Chief Financial Officer, Chief Corporate Governance Officer and Deputy Spokesperson to Vice President







Close

Supplied by: Bora Pharmaceuticals Co., LTD.

SEQ_NO

15

announcement date

2022/03/09

Announcement time

20:16:43

Topic

 Company's Board of Director's resolution
on promoting finance manager, corporate governance
manager and deputy spokesman to vice president

Date of events

2022/03/09

What item it responds to

paragraph 8

Declaration

1.Type of personnel changed (please enter:
spokesperson, acting spokesperson, important
personnel (CEO, COO, CMO, CSO, etc.), financial
 officer, accounting officer, corporate governance
officer, research and development officer, internal
 audit officer, or designated and non-designated
representatives):finance manager, corporate
governance manager and deputy spokesman
2.Date of occurrence of the change:2022/03/09
3.Name, title, and resume of the previous position holder:
Alice Wang/Finance Department Director
4.Name, title, and resume of the new position holder:
Alice Wang/Finance Department Vice President
5.Type of change (please enter: "resignation",
"position adjustment", "dismissal", "retirement",
"death" or "new replacement"):New replacement
6.Reason for the change:Position adjustment
7.Effective date:2022/03/09
8.Any other matters that need to be specified:The Company's Board of
Director approves this item on 2022/03/09.

Warning

Bora Pharmaceuticals Co. Ltd. published this content on March 09, 2022 and is solely responsible for the information contained therein. Distributed by publicunedited and unmodified, on March 09, 2022 12:21:07 UTC.

Public now 2022

All news from BORA PHARMACEUTICALS CO., LTD.

Sales 2021 4,900M
173M
173M
Net income 2021 755 million
26.6 million
26.6 million
Net debt 2021 2,863 million
101M
101M
PER 2021 ratio 15.8x
2021 performance 2.29%
Capitalization 12,108M
427M
427M
EV / Sales 2021 3.06x
EV / Sales 2022 2.61x
# of employees
Floating 54.1%

Chart BORA PHARMACEUTICALS CO., LTD.


Duration :

Period :




Bora Pharmaceuticals Co., LTD.  Technical Analysis Chart |  MarketScreener

Trending Technical Analysis BORA PHARMACEUTICALS CO., LTD.

Short term Middle term Long term
Tendencies Neutral Bearish Neutral



Evolution of the income statement

To sell

To buy

Medium consensus TO BUY
Number of analysts 2
Last closing price

TWD174.50

Average target price

TWD243.00

Average Spread / Target 39.3%


Comments are closed.